ClinicalTrials.govpublic full text
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
myositis, active idiopathic inflammatory myopathy, dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830049
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.